Home » Newsletters » BioWorld Science

BioWorld Science

March 2, 2011

View Archived Issues

Germline SNPs inked to outcome of docetaxel-treated metastatic castration-resistant prostate cancer

Soluble CD276 antigen in expressed prostatic secretions is a biomarker of chronic prostatitis

RITA has synergistic activity with chemotherapeutic agents in MM cells in vitro

Regeneron reports new phase III data on Arcalyst for prevention of gout flares

New modified sesamol derivative INV-403 suppresses atherosclerosis in vivo

Nile Therapeutics and Medtronic collaborate on development of cenderitide

New phase II trial evaluates Prostvac with docetaxel in prostate cancer

New inhibitors of cGMP-specific 3',5'-cyclic phosphodiesterase claimed

Pfizer completes acquisition of King Pharmaceuticals

New inhibitors patented of enoyl-[acyl-carrier-protein] reductase [NADH]

Kyorin and Almirall sign license agreement for aclidinium bromide in Japan

Daiichi Sankyo to acquire Plexxikon

Medivir's Xerese launched in the U.S. as prescription cold sore treatment

FDA grants Epeius' anticancer gene therapy Rexin-G phase III status

Mochida Pharma requests Japanese approval for Beselna in solar keratoses

Novartis seeks approval in Japan for Certican to prevent renal transplant rejection

Gemzar approved in Japan for ovarian cancer after chemotherapy

Novavax receives contract to develop flu vaccines for U.S. government

Seattle Genetics and Millennium begin phase I trial of brentuximab vedotin

Oxygen Biotherapeutics receives grant from U.S. army to study Oxycyte in traumatic brain injury

NPS Pharma advances pivotal REPLACE trial of NPSP-558 in hypoparathyroidism

European approval for Xiapex for Dupuytren's contracture

HIV reverse transcriptase inhibitors patented by AiCuris

Novel inhibitors of 11-beta-HSD1 presented

Selexagen discloses new sonic hedgehog protein inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...